Emily leverages more than a decade of experience in healthcare and life sciences law to provide strategic business and regulatory advice to a diverse range of clients. She is passionate about helping healthcare platforms, drug distributors, pharmacies, hospital systems, and outsourcing facilities, among others, navigate the complex and evolving Food and Drug Administration (“FDA”), Drug Enforcement Administration, and state regulations that govern their operations and transactions.
